Moreover, either DNMT3A or DNMT3B is found in many clinical tumor samples, and the increased expression of DNMT3A was previously reported to participate in the progression of hepatocellular carcinoma [49,50]. This evidence concerns the gene DNMT3B and hepatocellular carcinoma.